China Medtech Joint Ventures – Ordeal Or Adventure? Part 2
This article was originally published in PharmAsia News
An increasing number of SMEs are going down the joint venture route to establish a presence in the sizeable Chinese healthcare market. In this second instalment of a two-part feature, Tina Tan asks Enigma Diagnostics CEO John McKinley about his experiences of finding the right partner for a joint venture in China.